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Cell spreadinga b s t r a c t
The RhoGTPase Rac1 is activated in a polarised fashion and controls cell motility. We previously
showed that Rac1 binds the PP2A inhibitor SET and recruits nuclear SET to the cytosol. We show that
a SET mutant, lacking a nuclear localization signal, SET(DNLS), promotes cell spreading and motility.
This was accompanied by an increase in the number and frequency of membrane rufﬂes. Pharma-
cological inhibition of PP2A did not mimic the effects of SET(DNLS), however, we found that expres-
sion of SET and SET(DNLS) increases the levels of the MAP kinases ERK1 and ERK2.
Structured summary of protein interactions:
RAC1 physically interacts with SET by pull down (View interaction).
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Polarized cell motility is driven by actin polymerization and
membrane protrusion at the cell front in concert with formation
and remodelling of sites of integrin-mediated adhesion [1]. The
small GTPase Rac1 controls cell protrusion and actin polymeriza-
tion, mediated by the Arp2/3-complex. The small GTPase Rac1 is
a member of the family of RhoGTPases. These GTPases function
as molecular switches: activation is initiated by binding to GTP,
catalysed by Guanine-nucleotide Exchange Factors (GEFs) whereas
inactivation requires GTP hydrolysis, promoted by GTPase Activat-
ing Proteins (GAPs) [2,3]. GTP-bound Rac1 interacts with down-
stream effectors, including WASP and Wave proteins, IQGAP and
the PAK kinases [3]. Cell migration requires proper localization of
the relevant signaling components [4,5]. For Rac1, correct localiza-
tion requires a C-terminal lipid anchor in conjunction with an adja-
cent polybasic region. Our lab and others showed that the Rac1
hypervariable domain, which harbours the polybasic region also
binds to the GEF b-PIX, to Caveolin1 and PACSIN2, to the ubiquitin
ligase Nedd4 and mTOR [6–11]. In addition, Rac1 binds the proto-
oncogene and PP2A inhibitor SET/I2PP2A [12,13].In addition to inhibiting PP2A, SET controls histone acetylation,
granzyme activity and beta-adrenergic receptor phosphorylation
[14–16]. All these functions are involved in SET regulating apopto-
sis, the cell cycle as well as cell motility [12,14,15]. SET can be
phosphorylated by Casein Kinase II as well as PI3Kinase-c
[16,17], regulating SET dimerization, localization and function
[12,16]. Nuclear SET can shuttle to the cytoplasm [12,18,19]. We
previously showed that SET exits the nucleus in a seemingly ran-
dom fashion [18]. Nuclear exit of SET correlates with cell spread-
ing, in line with its proposed role in cell motility. We also found
that activated Rac1 and SET can exit the nucleus simultaneously
(Lam et al., unpublished data), which is in line with our data that
suggested SET to cooperate with Rac1 stimulating cell migration
[12]. To investigate this further, we here tested the effects of con-
stitutive cytoplasmic targeting of SET to the cytoplasm for cell
spreading, cell–cell contact, membrane rufﬂing and cell motility.
2. Methods
2.1. Antibodies, constructs and reagents
Antibodies against the following proteins were used: Anti-SET/
I2PP2A (SC-25564, Santa Cruz Biotechnology); GFP (632381,
Clontech); b-catenin (mouse monoclonal, 610154, Transduction
Laboratories) and ZO-1 (mouse monoclonal, 610966, Transduc-
tion Laboratories). F-Actin was detected using Texas-Red-
or Alexa-Fluor-633-labeled phalloidin (Invitrogen). Secondary
Alexa-Fluor-labeled antibodies for immunoﬂuorescence were
112 B.D. Lam et al. / FEBS Letters 587 (2013) 111–119from Invitrogen. FTY720 was obtained from Calbiochem
(344597).
2.2. Cell culture and transfection
HeLa cells were maintained and transfected using TransIT-LT1
Transfection Reagent (Mirus Bio) as descrived [18]. For prolifera-
tion assays, cells were counted using a cell counter (CASY), and cul-
tured in 6-well plates for 24, 48 and 96 h. After these time pointsFig. 1. Rac1 binding and localisation of the SET(DNLS) mutant. (A) Schematic drawing ind
(Nucleosome Assembly Protein) domain and the acidic C-terminus are indicated, as w
transfected as indictaed and SET binding to the Rac1 C-terminal peptide was analysed. T
lysate; PD, pull-down. (C) The localisation of YFP-SET(wt) and YFP-SET(DNLS)-mutant wa
SET(DNLS) proteins shows a clear localization in the cytoplasm as well as the nucleus.the cells were counted again and the result is normalised to cells
expressing YFP. Analysis of cell spreading by ECIS was performed
as described [8].
2.3. Expression constructs
YFP-SET and its mutants A9 and E9 were generated as previ-
ously described [18]. Site-directed mutagenesis was performed
on YFP-SET to delete amino acids 168–181 from SET based onicates the position and sequence of the bipartite NLS and its deletion in SET. The NAP
ell as the position of Ser9, a target site for phosphorylation. (B) HeLa cells were
he Rac1 C-terminal peptide bound to the SET construct equally well. TCL, total cell
s analysed by confocal imaging. Whereas YFP-SET(wt) is primarily nuclear, the YFP-
Scale bar, 20 lm.
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YFP-SET(DNLS; see also Fig. 1A). Primers for this mutation were:
50GGAAAGGATTTGACGCAGCATGAGGAACCAG (forward primer)
and CTGGTTCCTCATGCTGCGTCAAATCCTTTCC (reverse primer),
produced by the Eurogentec Oligo Centre, Belgium.
2.4. Pull-down assay
Biotinylated peptides were synthesized on a peptide synthe-
sizer (Syro II) using FMOC solid phase chemistry. Peptides encoded
a protein transduction domain (Biotin-YARAAARQARAG) followed
by 10 amino acids N-terminal to the CAAX domain of Rac1. Peptide
pull-downs were performed using cell lysates and analysed as de-
scribed previously [7].Fig. 2. Cytoplasmic targeting of SET promotes cell migration. Cells were transfected as
imaging. (A) Raw images are recorded from an EMCCD-camera connected to a wide-ﬁeld
boundaries. After thresholding, single cells in the middle of the wound are removed usin
measured in time. (B) Wound healing (i.e., reduction in would area) is plotted as a fu
expression of SET(DNLS) enhances wound healing. Dashed line indicates point of ﬁrst ful
constructs at the time-poit indicated by the dashed line in B.2.5. Confocal laser scanning microscopy and kymographs
Cells were seeded onto ﬁbronectin-coated glass coverslips,
transfected with the indicated plasmids, ﬁxed and immunostained
as described [8]. Fluorescent imaging was performed with a confo-
cal laser-scanning microscope (LSM510/Meta; Carl Zeiss MicroI-
maging) using a 63 NA 1.40 or a 40 NA 1.30 oil lens (Carl
Zeiss MicroImaging). Image acquisition was performed with Zen
2009 software (Carl Zeiss MicroImaging). For live-cell imaging,
cells were seeded on ﬁbronectin-coated glass coverslips, transfec-
ted with the indicated plasmids. After 24 h, ﬂuorescent imaging
was performed. For kymography, imaging was performed on an
Axiovert 200M microscope (Carl Zeiss MicroImaging) using a
20 Plan-Neoﬂuar phase 2 air objective for scratch assays and aindicated, wounded and wound healing was recorded by live-cell phase-contrast
microscope. A Gaussian blur is applied with a variance ﬁlter to highlight the scratch
g a binary ﬁll-operation. Finally, the image is inverted and the area of the scratch is
nction of time. Expression of wild type SET (SET) delays wound healing, whereas
l wound closure. (C) Bar graph represents the area of wound closure for the different
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by a CCD camera (ORCA-R2, Hamamatsu Photonics) with an inter-
val of 5 min for scratch assays and 0.5 s for kymographs. For
analysing signiﬁcance levels from the kymograph data, the non-
parametric Mann-Witney U-test was used.
2.6. Nanopro assay
Total levels and phosphorylation of ERK was measured in cell
lysates by the Nanopro 1000 System (Protein Simple). 48 h after
transfection with the indicated constructs, cells were lysed in Bi-
cine/CHAPS lysis buffer (Protein Simple; 040–327) supplemented
with 1 DMSO Inhibitor Mix (Protein Simple; 040–510) and 1
Aqueous Inhibitor Mix (Protein Simple; 040–482). Following cen-
trifugation of lysates at 20.000g for 10 min at 4 C, supernatant
was loaded in small capillaries (Protein Simple) together with
Ampholyte premix G2 (Protein Simple; 040–973) and pI Standard
Ladder 3 (Protein Simple; 040–646). Proteins were separated by
isoelectric focusing by applying 21000 lW for 40 min, followed
by UV-cross linking, immuno-staining and recording by a CCD
camera. Data were analysed by company software (Compass; Pro-
tein Simple).
3. Results
We generated a mutant of YFP-tagged SET that is constitutively
cytoplasmic due to the lack of a nuclear localization signal (NLS)
[19], i.e., 168KRSSQTQNKASRKR181 (Fig. 1A). We previously deter-
mined that Rac1 binding to SET required the C-terminal portion
of the NAP (Nucleosome Assembly Protein) domain. Since the
NLS resides also in the C-terminal portion of the NAP domain, we
ﬁrst tested whether the YFP-SET(DNLS) mutant, expressed in HeLa
cells, still bound the Rac1 C-terminal peptide. Fig. 1B shows thatFig. 3. Constitutively cytoplasmic SET(DNLS) promotes cell spreading. (A–C) Cells were t
recorded in real time. Whereas expression of YFP-SET(WT) or its Ser9 mutants consis
increased cell spreading. (D) Cells were transfected as indicated and cell numbers werebinding of the Rac1 C-terminus to full-length YFP-SET (wt) is
equally efﬁcient as to the YFP-SET(DNLS) mutant. In addition, we
found that increasing Rac1 activity by co-expression of constitu-
tively active Rac1Q61 or Rac1V12 mutants did not alter the inter-
action of YFP-SET (wt) or YFP-SET(DNLS) with the Rac1 C-terminus
(not shown).
We next used confocal imaging of transfected HeLa cells to
determine whether cytoplasmic targeting of SET alters cellular dis-
tribution of cytoskeletal proteins and proteins, important for cell
adhesion and migration. Fig. 1C shows that the YFP-SET(DNLS),
in agreement with published data [19], is localised both in the nu-
cleus and in the cytoplasm. Cytoplasmic distribution was diffuse,
although in cells with higher expression, YFP-SET(DNLS) localised
to peripheral membrane rufﬂes (Fig. 1C). There was no obvious
co-localization with either F-actin, tubulin or vinculin (Fig. 1C–E).
In addition, expression of YFP-SET(DNLS) did not induce altered
distribution of F-actin, tubulin or vinculin. This data conﬁrms that
the region between amino acid 168–181 functions as a nuclear
localization signal.
Our previous analysis of the role of SET in Rac1 signalling indi-
cated that SET, once outside the nucleus, promotes cell migration
[12]. However, more recent work showed that nuclear exit of wild
type SET is not accompanied by clear membrane association [18],
which is why we used the YFP-SET(DNLS) mutant, which better
recapitulates the distribution of wt SET. We used YFP-SET(DNLS)
to study the effects of cytoplasmic SET on cell migration in more
detail, using transfected HeLa cells in a wound-healing assay.
We developed an image analysis protocol to quantify the
wound-healing response. Wounded monolayers were imaged by
phase-contrast microscopy (Fig. 2A) with a 5 min frame interval.
Images were processed using ImageJ. First a smoothing ﬁlter is ap-
plied, which replaces each pixel value with the average of its 3  3
neighbourhood to ﬁlter out small image noise. A variance ﬁlter isransfected as indicated and seeded after 24 h on ECIS electrodes. Cell spreading was
tently delayed initial spreading, expression of YFP-SET(DNLS) or its Ser9 mutants
counted 48 h after transfection and normalised to the values of the vector control.
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ary threshold. Consequently, the holes in the binary image, result-
ing from cells wich are migrating apart from the scratch front, are
ﬁlled, as well as the holes resulting from gaps in the monolayer of
cells. For each time point the area (=number of pixels) occupied by
the wound is measured and normalised to 100% at t = 0 min, which
is the start of the experiment. The results show that cells express-
ing the YFP-SET(DNLS)-mutant close the wound faster (on average
400–500 min) compared to cells expressing wt SET, YFP, or no con-
struct at all (Fig. 2B). The relative % of wound healing at time point
440 min, the moment at which the wound is closed in the YFP-
SET(DNLS) cells, are displayed in Fig. 2C. The ImageJ analysis macro
for this method is included in Supplementary File 1.
To determine whether also cell spreading was enhanced we
seeded HeLa cells, transfected with YFP-SET (wt) or YFP-SET(DNLS)
on ECIS electrodes which allow real time recordings of cell spread-
ing [8,10]. In cells expressing the YFP-SET(DNLS), we observed a
higher resistance during spreading compared to YFP (Fig. 3A).
Expression of YFP-SET(wt) gave an opposite response in that in
these cells, electrical resistance during spreading was lower com-
pared to the YFP control (Fig. 3A). This data suggests that wild-type
SET impairs cell spreading, whereas constitutively cytoplasmicFig. 4. Distribution of junctional proteins is not altered by expression of YFP-SET(?NLS).
were ﬁxed, immunostained for b-catenin (A) as a marker for adherens junctions or ZO-
proﬁles along the indicated lines are in the right panels. Expression of SET constructs dYFP-SET(DNLS) promotes cell spreading. Moreover, the transepi-
thelial resistance of the epithelial monolayers was also higher
compared to the controls, suggesting that YFP-SET(DNLS) also pro-
motes intercellular contacts (see below).
Previously, we showed that the phospho-mimetic E9 mutant of
SET shows increased cytoplasmic localisation, whereas the corre-
sponding A9 mutant was strictly nuclear [12,18]. We generated
the DNLS mutation also in the background of the A9 and E9 mu-
tants to test for co-operativity of these mutations. The data in
Fig. 3B, C show that also in these mutants, the DNLS mutation pro-
moted cell spreading compared to the A9 or E9 versions of SET(wt).
Finally, we tested whether altered cell proliferation could explain
our increased resistance values, but found no indications that
expression of either YFP-SET(wt) or YFP-SET(DNLS) altered cell
numbers after 48 h of culture (Fig. 3D).
Differences in electrical resistance over a monolayer of epithe-
lial cells can also be due to increased junctional integrity. We
therefore analysed transfected cells for b-catenin, as a marker for
adherens junctions, and for ZO-1 (Zona Occludens-1) as a marker
for tight junctions (Fig. 4A,B). Intensity plots along the indicated
lines are included to underscore local protein distribution at cell–
cell contacts. These data showed no signiﬁcant changes in theCells were transfected on glass slides and cultured to conﬂuency for 24 h. Next cells
1 (B) as a marker for tight junctions and imaged by confocal microscopy. Intensity
id not induce major changes in distribution of b-catenin or ZO-1.
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Western blotting of transfected cells also showed no signiﬁcant
changes in overall ZO-1 levels (data not shown).
Since the YFP-SET(DNLS) promoted cell migration as well as cell
spreading in HeLa cells, we performed a more detailed analysis of
membrane rufﬂing activity. This was done using live-cell phase
contrast imaging in combination with kymograph analysis, based
on SACED (stroboscopic analysis of cell dynamics) [20]. In this ap-
proach, phase contrast images are recorded with a frequency of
2 Hz (i.e., two images per second, Fig. 5A-a0). Eight equally distrib-
uted radial line proﬁles are measured in time (Fig. 5A-a00). Exam-
ples of the ﬁrst four kymographs are shown in Fig. 5A, in the
panels marked 1–4. Membrane rufﬂes were analysed by optical
inspection (Fig. 5A-a000 zoom). Based on the indicated lines, the total
number of membrane rufﬂes in the experiment (‘count’), the fre-
quency (#/time), length (l) and speed (dist/time = tan(a)) of theFig. 5. Cytoplasmic targeting of SET promotes membrane rufﬂe dynamics. (A) Live-cell p
drawn from 8 radially arranged lines (panel A-a00). Panels marked 1–4 are included as e
rufﬂes are counted and classiﬁed by eye, with values for distance, time and length com
distance over time, frequency as number (count) over time. (B) Kymograph analysis sho
YFP-SET(DNLS) is due to an increase in the number of membrane rufﬂes, an increase in t
membrane rufﬂe length. ⁄, p < 0.05; ⁄⁄, p < 0.01; ⁄⁄⁄, p < 0.001.membrane rufﬂes can be calculated (Fig. 5B). This analysis showed
that the number and frequency of membrane rufﬂes is higher in
cells expressing the YFP-SET(DNLS)-mutant as compared to cells
expressing wildtype YFP-SET (WT). The speed of the individual ruf-
ﬂes is also higher in the YFP-SET(DNLS)-mutant expressing cells,
while the length is signiﬁcantly shorter. Thus, cells, expressing
the YFP-SET(DNLS)-mutant show increased membrane dynamics,
in line with the increased cell spreading and the increased speed
of wound healing.
Because PP2A activity has been linked to the control of cell
migration in a positive as well as negative fashion [21,22], we
tested whether inhibition of PP2A would mimic the effects of
YFP-SET(DNLS). We used increasing doses of okadaic acid, a widely
used PP2A inhibitor in the wound healing assays and quantiﬁed
the response by live-cell imaging as described for Fig. 2 (Fig. 6A).
However, we observed a dose-dependent inhibition of wouldhase contrast imaging (2 frames/s) of rufﬂing cells (panel A-a0). (A) Kymographs are
xamples and represent the kymographs along the corresponding lines. Membrane
puted from the manually drawn line regions (panel A-a000). Speed is calculated as
w that the difference in membrane dynamics of cells expressing either YFP-SET or
he frequency and speed of these membrane rufﬂes and a corresponding decrease in
Fig. 6. Inhibition of PP2A by okadaic acid does not mimic cytoplasmic targeting of SET. Cells were grown to conﬂuency on glass slides, incubated with the indicated
concentrations of the PP2A inhibitor okadaic acid and assayed for wound healing by live cell imaging as in Fig. 2 in the presence of the inhibitor. (A) Graph shows wound
healing as a function of time at the indicated concentrations of okadaic acid. (B) Bar graphs shows values of area closure corresponding to the dashed line in panel A.
Fig. 7. Analysis of ERK1/2 by Nanopro technology. (A) The Nanopro iso-electric focusing assay was used to quantitatively measure ERK phosphorylation. In resting cells,
unphosphorylated Erk1 and Erk2 are the major species with small quantities of phosphorylated ERK1,2 detectable. The phosphorylated ERK species are indicated. (B)
Expression of YFP-SET(wt) or YFP-SET(DNLS) causes a small but not signiﬁcant reduction in ERK1 phosphorylation levels. (C) Nanopro analysis of total ERK1 and ERK2 in
lysates from cells, transfected with YFP (blue), YFP-SET (green) or YFPSET(DNLS) (grey). (D) The increase in total ERK1/2 levels in cells expressing the indicated constructs are
quantiﬁed and the mean values ±sd (n = 6) is shown in the bar graph.
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et al. [21] This data suggests that inhibition of PP2A is not the
mechanism by which cytoplasmic SET promotes cell spreading
and migration. However, siRNA-mediated removal of the different
PP2A isoforms expressed in these cells would be required to pro-
vide formal proof for this conclusion.
To study other signaling pathways that may be affected by cyto-
plasmic targeting of SET, we analysed activation of ERK1/2. For
analysis of phosphorylation of the p42 and p44 ERK kinases, we
used the Nanopro assay as described in Methods [23] (Fig. 7A).
We checked whether the phosphorylation of MAP-kinases was al-
tered by re-localising SET from the nucleus to the cytoplasm
(Fig. 7B). For analysis of ERK phosphorylation, the total ERK anti-
body was used since the phosphorylated species of ERK1 and
ERK2 have a reduced, iso-electric point (pI, Fig. 7A) The data show
that expression of YFP-SET(wt) or YFP-SET(DNLS) induces a slight
but insigniﬁcant reduction in ERK1 (Fig. 7B) – and ERK2 (not
shown) phosphorylation. However, we noted in 5 out of 6 indepen-
dent experiments that the levels of unphosphorylated, total ERK1
and ERK2 were elevated in the cells expressing YFP-SET(wt) and
in particular in cell expressing YFP-SET(DNLS) (Fig. 7C,D). The in-
crease in ERK levels amounted up to three-fold, compared to
YFP-transfected control cells. Whether this increase in ERK levels
is the result of increased protein synthesis or reduced degradation
remains to be established.4. Discussion
Increasing numbers of signaling proteins that originally were
regarded to be cytoplasmic, are now known to reside in the nu-
cleus as well and vice versa. SET/I2PP2A is also known to localise
to the nucleus as well as the cytoplasm [18,24]. We previously
found that Rac1 binds, through its hypervariable C-terminus, to
the NAP domain of SET [12]. Our initial ﬁndings suggested that
Rac1 activity promotes cytoplasmic accumulation of SET which
could stimulate Rac1-mediated cell motility [12]. We generated a
constitutively cytoplasmic mutant of SET which lacks the non-
canonical bipartite nuclear localization in SET [19] and mimics
more closely the normal localisation of SET that has exited the nu-
cleus [18].
We used a wound-healing assay to measure cell migration
speed as a function of time. We developed an image-analysis
method based on continuous monitoring of the size of the wound,
to record the speed of the would healing response in real time. In
line with our earlier ﬁndings, cytoplasmic localization of SET pro-
motes wound healing whereas expression of SET(WT) reduced cell
migration. To further determine which cellular responses are af-
fected by cytoplasmic targeting of SET we analysed cell spreading,
membrane rufﬂing and intracellular signaling. Our ﬁndings show
that in addition to the wound healing, SET(DNLS) also promotes
cell spreading. The spreading, as was recorded using ECIS-based
impedance measurements, was approximately two-fold higher as
compared to controls. This effect was independent from mutation
at Ser9, most likely because the SET(DNLS) mutation bypasses reg-
ulatory events (i.e., phosphorylation) that target this residue.
The increase in electrical resistance can, in addition to spread-
ing, also be the result of enhanced intercellular contact. However,
we could not ﬁnd any signiﬁcant changes in the distribution of F-
actin or b-catenin, both markers for adherens junctions, or for
ZO-1, a marker for tight junctions in control cells or in cells
expressing SET(WT) or SET(DNLS). This underscores the notion
that cytoplasmic targeting of SET promotes cell spreading rather
than cell–cell contact.
Since cell spreading and migration is dependent on actin poly-
merization and consequent membrane dynamics and protrusion,we used detailed kymograph analysis [20] based on live-cell
recordings to analyse membrane dynamics in SET or SET(DNLS)–
expressing cells. These studies showed that cytoplasmic targeting
of SET does alter membrane dynamics. The number, speed and fre-
quency of membrane rufﬂes were increased, but these rufﬂes were
consequently shorter. These changes in membrane dynamics cor-
relate well with the increased cell migration in the wound healing
assay.
To investigate which signaling events may be relevant for the
induction of cell motility by cytoplasmic SET, we also focused on
PP2A. However, inhibition of PP2A by okadaic acid dose-depen-
dently blocked the wound-healing response in the scratch assays,
opposite to the effect we observed with SET(DNLS). The ﬁnding
that okadaic acid inhibits cell motility has also been observed in
CD34+-cells [22] and MCF7 epithelial cells [25]. Our ﬁndings sug-
gest, however, that inhibition of PP2A does not mediate the stimu-
latory effects of cytoplasmic SET on cell motility.
Finally, we tested effects of SET on basal activity of the ERK ki-
nases, that were previously linked to cell motility [26]. We used a
novel technique, based on capillary iso-electric focusing, to mea-
sure expression and phosphorylation of ERK1 and ERK2. These
experiments revealed that there were no signiﬁcant differences
in ERK1/2 phosphorylation in the absence or presence of SET. How-
ever, we noted a consistent increase in the levels of total, unphos-
phorylated ERK1 and ERK2 in cells, expressing SET and the
SET(DNLS) mutant. ERK signaling is linked to cell migration and
is activated by many stimuli, including integrins that in parallel
also activate Rac1 [26,27]. Moreover, ERK can associate to PP2A
[28], suggesting that cell migration may be regulated through a
Rac1-SET-PP2A-ERK signaling complex. The conditions that deter-
mine the output and level of such signaling including the levels of
ERK activity, require further investigations.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.febslet.2012.
11.013.
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